Contents

Current Pharmaceutical Design, Volume 21 - Number 39

Editorial

Editorial (Thematic Issue: Neonatal and Pediatric Clinical Pharmacology)

, 21(39): 5617 - 5618

John N. van den Anker


DOI: 10.2174/138161282139151116095212




Ethical Considerations in Conducting Pediatric and Neonatal Research in Clinical Pharmacology

, 21(39): 5619 - 5635

Michelle Roth-Cline and Robert M. Nelson


DOI: 10.2174/1381612821666150901105146




Functional Biomarkers: an Approach to Bridge Pharmacokinetics and Pharmacodynamics in Pediatric Clinical Trials

, 21(39): 5636 - 5642

Gregory L. Kearns and Michael Artman


DOI: 10.2174/1381612821666150901105337




New Ways of Detecting ADRs in Neonates and Children

, 21(39): 5643 - 5649

Ricardo Jimenez, Anne Smith and Bruce Carleton


DOI: 10.2174/1381612821666150901105555




Clinical Pharmacology of Frequently Used Intravenous Drugs During Bariatric Surgery in Adolescents

, 21(39): 5650 - 5659

Janelle D. Vaughns, Victoria C. Ziesenitz and John N. van den Anker


DOI: 10.2174/1381612821666150901105736




Pharmacotherapy of Sickle Cell Disease in Children

, 21(39): 5660 - 5667

Kathleen A. Neville and Julie A. Panepinto


DOI: 10.2174/1381612821666151030105213




Availability of Oral Formulations Labeled for Use in Young Children in Serbia, Germany and the USA

, 21(39): 5668 - 5673

Milica Bajcetic, Gregory L. Kearns, Ida Jovanovic, Milan Brajovic and John N. van den Anker


DOI: 10.2174/1381612821666150901105925




Neonatal Formulations: The Need for a Tailored, Knowledge Driven Approach

, 21(39): 5674 - 5679

Karel Allegaert, Katrien Cosaert and John N. van den Anker


DOI: 10.2174/1381612821666150901110207




Why are Excipients Important to Neonates?

, 21(39): 5680 - 5687

Mark A. Turner and Utpal Shah


DOI: 10.2174/1381612821666150901110341




Development of a Physiologically-Based Pharmacokinetic Model for Preterm Neonates: Evaluation with In Vivo Data

, 21(39): 5688 - 5698

Karina Claassen, Kirstin Thelen, Katrin Coboeken, Thomas Gaub, Jorg Lippert, Karel Allegaert and Stefan Willmann


DOI: 10.2174/1381612821666150901110533




Dosing Guidelines of Aminoglycosides in Neonates: A Balance Between Physiology and Feasibility

, 21(39): 5699 - 5704

Karel Allegaert, Veerle Cossey and John N. van den Anker


DOI: 10.2174/1381612821666150901110659




The Impact of Hypothermia on the Pharmacokinetics of Drugs Used in Neonates and Young Infants

, 21(39): 5705 - 5724

P. Pokorna, E.D. Wildschut, V. Vobruba, John N. van den Anker and D. Tibboel


DOI: 10.2174/1381612821666150901110929




The Potential Effect of Fluorinated Compounds in the Treatment of Alzheimer’s Disease

, 21(39): 5725 - 5735

Barbara Gomes, Joana A. Loureiro, Manuel A.N. Coelho and Maria do Carmo Pereira


DOI: 10.2174/1381612821666150130120358




Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a-/- Model

, 21(39): 5736 - 5748

Jana Urbanova, Michal Andel, Jana Potockova, Josef Klima, Jan Macek, Pavel Ptacek, Vaclav Mat’oska, Tereza Kumstyrova and Petr Heneberg


DOI: 10.2174/1381612821666151008124036




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science